Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

Related Citations for PubMed (Select 24120944)

1.

Inhibitory effect of Nodal on the expression of aldehyde dehydrogenase 1 in endometrioid adenocarcinoma of uterus.

Wang Y, Jiang Y, Tian T, Hori Y, Wada N, Ikeda J, Morii E.

Biochem Biophys Res Commun. 2013 Nov 1;440(4):731-6. doi: 10.1016/j.bbrc.2013.09.139. Epub 2013 Oct 8.

PMID:
24120944
2.

Expression of aldehyde dehydrogenase 1 (ALDH1) in endometrioid adenocarcinoma and its clinical implications.

Rahadiani N, Ikeda J, Mamat S, Matsuzaki S, Ueda Y, Umehara R, Tian T, Wang Y, Enomoto T, Kimura T, Aozasa K, Morii E.

Cancer Sci. 2011 Apr;102(4):903-8. doi: 10.1111/j.1349-7006.2011.01864.x. Epub 2011 Feb 9.

PMID:
21231983
3.

Roles of histamine on the expression of aldehyde dehydrogenase 1 in endometrioid adenocarcinoma cell line.

Wang Y, Jiang Y, Ikeda J, Tian T, Sato A, Ohtsu H, Morii E.

Cancer Med. 2014 Oct;3(5):1126-35. doi: 10.1002/cam4.296. Epub 2014 Jul 10.

4.

ALDH1-high ovarian cancer stem-like cells can be isolated from serous and clear cell adenocarcinoma cells, and ALDH1 high expression is associated with poor prognosis.

Kuroda T, Hirohashi Y, Torigoe T, Yasuda K, Takahashi A, Asanuma H, Morita R, Mariya T, Asano T, Mizuuchi M, Saito T, Sato N.

PLoS One. 2013 Jun 6;8(6):e65158. doi: 10.1371/journal.pone.0065158. Print 2013.

5.

Coordinated expression of REG4 and aldehyde dehydrogenase 1 regulating tumourigenic capacity of diffuse-type gastric carcinoma-initiating cells is inhibited by TGF-β.

Katsuno Y, Ehata S, Yashiro M, Yanagihara K, Hirakawa K, Miyazono K.

J Pathol. 2012 Nov;228(3):391-404. doi: 10.1002/path.4020. Epub 2012 May 8.

PMID:
22430847
6.

Fibroblasts induce expression of FGF4 in ovarian cancer stem-like cells/cancer-initiating cells and upregulate their tumor initiation capacity.

Yasuda K, Torigoe T, Mariya T, Asano T, Kuroda T, Matsuzaki J, Ikeda K, Yamauchi M, Emori M, Asanuma H, Hasegawa T, Saito T, Hirohashi Y, Sato N.

Lab Invest. 2014 Dec;94(12):1355-69. doi: 10.1038/labinvest.2014.122. Epub 2014 Oct 20.

PMID:
25329002
7.

Gene expression profiles of prostate cancer stem cells isolated by aldehyde dehydrogenase activity assay.

Nishida S, Hirohashi Y, Torigoe T, Kitamura H, Takahashi A, Masumori N, Tsukamoto T, Sato N.

J Urol. 2012 Jul;188(1):294-9. doi: 10.1016/j.juro.2012.02.2555. Epub 2012 May 16.

PMID:
22608744
8.

Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers.

Deng S, Yang X, Lassus H, Liang S, Kaur S, Ye Q, Li C, Wang LP, Roby KF, Orsulic S, Connolly DC, Zhang Y, Montone K, Bützow R, Coukos G, Zhang L.

PLoS One. 2010 Apr 21;5(4):e10277. doi: 10.1371/journal.pone.0010277.

9.

Aldehyde dehydrogenase 1/epidermal growth factor receptor coexpression is characteristic of a highly aggressive, poor-prognosis subgroup of high-grade serous ovarian carcinoma.

Liebscher CA, Prinzler J, Sinn BV, Budczies J, Denkert C, Noske A, Sehouli J, Braicu EI, Dietel M, Darb-Esfahani S.

Hum Pathol. 2013 Aug;44(8):1465-71. doi: 10.1016/j.humpath.2012.12.016. Epub 2013 Mar 1.

PMID:
23465277
10.

In vitro and in vivo expression of aldehyde dehydrogenase 1 in oral squamous cell carcinoma.

Ota N, Ohno J, Seno K, Taniguchi K, Ozeki S.

Int J Oncol. 2014 Feb;44(2):435-42. doi: 10.3892/ijo.2013.2188. Epub 2013 Nov 27.

PMID:
24285422
11.

The expression of ALDH1 in cervical carcinoma.

Yao T, Chen Q, Zhang B, Zhou H, Lin Z.

Med Sci Monit. 2011 Aug;17(8):HY21-26.

12.

Aldehyde dehydrogenase 1, a potential marker for cancer stem cells in human sarcoma.

Lohberger B, Rinner B, Stuendl N, Absenger M, Liegl-Atzwanger B, Walzer SM, Windhager R, Leithner A.

PLoS One. 2012;7(8):e43664. doi: 10.1371/journal.pone.0043664. Epub 2012 Aug 23.

13.

ALDH1 expression correlates with favorable prognosis in ovarian cancers.

Chang B, Liu G, Xue F, Rosen DG, Xiao L, Wang X, Liu J.

Mod Pathol. 2009 Jun;22(6):817-23. doi: 10.1038/modpathol.2009.35. Epub 2009 Mar 27.

14.

Aldehyde dehydrogenase 1 expression predicts poor prognosis in triple-negative breast cancer.

Ohi Y, Umekita Y, Yoshioka T, Souda M, Rai Y, Sagara Y, Sagara Y, Sagara Y, Tanimoto A.

Histopathology. 2011 Oct;59(4):776-80. doi: 10.1111/j.1365-2559.2011.03884.x.

PMID:
22014057
15.

Association of aldehyde dehydrogenase 1 expression and biologically aggressive features in breast cancer.

Kang EJ, Jung H, Woo OH, Park KH, Woo SU, Yang DS, Kim AR, Lee JB, Kim YH, Kim JS, Seo JH.

Neoplasma. 2014;61(3):352-62.

PMID:
24824938
16.

Prognostic impact of the expression of ALDH1 and SOX2 in urothelial cancer of the upper urinary tract.

Kitamura H, Torigoe T, Hirohashi Y, Asanuma H, Inoue R, Nishida S, Tanaka T, Fukuta F, Masumori N, Sato N, Tsukamoto T.

Mod Pathol. 2013 Jan;26(1):117-24. doi: 10.1038/modpathol.2012.139. Epub 2012 Aug 17.

17.

Prognostic impact of the cancer stem cell related markers ALDH1 and EZH2 in triple negative and basal-like breast cancers.

De Brot M, Rocha RM, Soares FA, Gobbi H.

Pathology. 2012 Jun;44(4):303-12. doi: 10.1097/PAT.0b013e3283534bcb.

PMID:
22544210
18.

Expression of a novel oncofetal mRNA-binding protein IMP3 in endometrial carcinomas: diagnostic significance and clinicopathologic correlations.

Li C, Zota V, Woda BA, Rock KL, Fraire AE, Jiang Z, Lu D, Xu B, Dresser K, Lutman CV, Fischer AH.

Mod Pathol. 2007 Dec;20(12):1263-8. Epub 2007 Sep 21.

19.

Aldehyde dehydrogenase 1, a functional marker for identifying cancer stem cells in human nasopharyngeal carcinoma.

Wu A, Luo W, Zhang Q, Yang Z, Zhang G, Li S, Yao K.

Cancer Lett. 2013 Apr 28;330(2):181-9. doi: 10.1016/j.canlet.2012.11.046. Epub 2012 Dec 5.

PMID:
23220285
20.

Lymphatic invasion according to D2-40 immunostaining is a predictor of nodal metastasis in endometrioid adenocarcinoma of the uterine corpus.

Miyakuni Y, Matsumoto T, Arakawa A, Sonoue H, Suzuki C, Takeda S.

Pathol Int. 2008 Aug;58(8):471-6. doi: 10.1111/j.1440-1827.2008.02258.x.

PMID:
18705765
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk